JPRN-UMIN000037200已完成未知
A study to investigate the efficacy and dose response of Euglena by questionnaires for a measure of the subjective well-being - A study to investigate the efficacy and dose response of Euglena by questionnaires for a measure of the subjective well-being
everage Brain Inc.0 个研究点目标入组 210 人开始时间: 2019年7月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Subjects who are under pharmacological treatment for chronic disorders, especially subjects who take Warfarin 2)Subjects who have histories of mental disorders (Depression etc.) 3)Subjects work irregular hours on the night shift or irregular shift 4)Subjects who had participated in other clinical trials or monitoring studies within 1 month 5)Subjects who have intolerance to study food substance 6)Subjects who are in pregnancy, lactation, or who are willing to become pregnant 7)Subjects who are ineligible due to the chief inspector's judgment
研究者
相似试验
已完成
3 期
Dose Response Study of a Complementary Medicine Formulation in Primary HypercholesterolaemiaACTRN12605000232639Pathways40
已完成
Unknown
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK)ot applicableJPRN-UMIN000051748Suntory Wellness Limited200
进行中（未招募）
不适用
Dose finding study (phase II) to investigate efficacy and tolerability of a 6 month oral treatment with three different strenghts of selenium (trade name: Cefasel) compared to placebo in patients with autoimmune thyroiditis (Hashimoto's disease, inflammation of the thyroid):double blind, random allocation to treatment groupsEUCTR2007-001107-38-DECefak KG200
进行中（未招募）
不适用
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthmahouse dust mite-associated allergic asthmaMedDRA version: 17.0Level: LLTClassification code 10020419Term: House dust mite allergySystem Organ Class: 100000004870MedDRA version: 17.0Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855EUCTR2013-000487-28-DESTALLERGENES SA480
进行中（未招募）
1 期
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthmahouse dust mite-associated allergic asthmaMedDRA version: 14.1Level: LLTClassification code 10020419Term: House dust mite allergySystem Organ Class: 100000004870MedDRA version: 14.1Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855EUCTR2013-000487-28-SKSTALLERGENES SA480